Clinical trial
Phase II Study of Heme Arginate in Patients Planned for Cardiac Surgery
NCT02142699 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Heme Arginate in Patients Planned for Cardiac Surgery
- Lead sponsor
- University of Edinburgh
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 17, 2014
- Completion date
- November 16, 2015
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.